Craig Wong-Pan
Stock Analyst at RBC Capital
(0.71)
# 3,816
Out of 4,355 analysts
295
Total ratings
46.3%
Success rate
-2.7%
Average return
Main Sectors:
Stocks Rated by Craig Wong-Pan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: IDX Integral Diagnostics Limited | Maintained: Buy | $3.20 → $3.05 | $2.17 | +40.55% | 21 | May 28, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Upgraded: Hold | $37.44 → $34.00 | $37.29 | -8.82% | 4 | May 26, 2026 | |
| ASX: REG Regis Healthcare Limited | Upgraded: Buy | $8.00 → $7.50 | $6.58 | +13.98% | 27 | May 25, 2026 | |
| ASX: ALC Alcidion Group Limited | Maintained: Hold | $0.12 → $0.13 | $0.107 | +21.50% | 22 | May 18, 2026 | |
| ASX: HLS Healius Limited | Downgraded: Sell | $0.75 → $0.35 | $0.34 | +2.94% | 29 | May 13, 2026 | |
| ASX: CSL CSL Limited | Maintained: Hold | $176.00 → $113.00 | $96.61 | +16.97% | 31 | May 11, 2026 | |
| RMD ResMed | Maintained: Buy | $311 → $321 | $190.57 | +68.44% | 34 | May 1, 2026 | |
| ASX: COH Cochlear Limited | Maintained: Buy | $297.00 → $125.00 | $100.50 | +24.38% | 20 | Apr 22, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $18.00 | $13.03 | +38.14% | 5 | Apr 15, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Maintained: Hold | $36.00 → $45.00 | $37.09 | +21.33% | 21 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.75 | $0.71 | +5.63% | 12 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.00 → $3.75 | $3.16 | +18.67% | 17 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23.00 → $25.00 | $19.52 | +28.07% | 23 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41.00 | $27.85 | +47.22% | 7 | Feb 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.80 → $2.40 | $2.03 | +18.23% | 19 | Feb 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $16.04 | $24.84 | n/a | 1 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31.60 | $12.41 | n/a | 1 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $6.57 | $23.59 | n/a | 1 | May 22, 2019 |
Integral Diagnostics Limited
May 28, 2026
Maintained: Buy
Price Target: $3.20 → $3.05
Current: $2.17
Upside: +40.55%
Fisher & Paykel Healthcare Corporation Limited
May 26, 2026
Upgraded: Hold
Price Target: $37.44 → $34.00
Current: $37.29
Upside: -8.82%
Regis Healthcare Limited
May 25, 2026
Upgraded: Buy
Price Target: $8.00 → $7.50
Current: $6.58
Upside: +13.98%
Alcidion Group Limited
May 18, 2026
Maintained: Hold
Price Target: $0.12 → $0.13
Current: $0.107
Upside: +21.50%
Healius Limited
May 13, 2026
Downgraded: Sell
Price Target: $0.75 → $0.35
Current: $0.34
Upside: +2.94%
CSL Limited
May 11, 2026
Maintained: Hold
Price Target: $176.00 → $113.00
Current: $96.61
Upside: +16.97%
ResMed
May 1, 2026
Maintained: Buy
Price Target: $311 → $321
Current: $190.57
Upside: +68.44%
Cochlear Limited
Apr 22, 2026
Maintained: Buy
Price Target: $297.00 → $125.00
Current: $100.50
Upside: +24.38%
Telix Pharmaceuticals Limited
Apr 15, 2026
Maintained: Buy
Price Target: $18.00
Current: $13.03
Upside: +38.14%
Ramsay Health Care Limited
Feb 26, 2026
Maintained: Hold
Price Target: $36.00 → $45.00
Current: $37.09
Upside: +21.33%
Feb 26, 2026
Maintained: Hold
Price Target: $0.75
Current: $0.71
Upside: +5.63%
Feb 24, 2026
Maintained: Hold
Price Target: $4.00 → $3.75
Current: $3.16
Upside: +18.67%
Feb 19, 2026
Maintained: Hold
Price Target: $23.00 → $25.00
Current: $19.52
Upside: +28.07%
Feb 16, 2026
Maintained: Buy
Price Target: $41.00
Current: $27.85
Upside: +47.22%
Feb 16, 2026
Maintained: Hold
Price Target: $2.80 → $2.40
Current: $2.03
Upside: +18.23%
Oct 6, 2020
Maintained: Sell
Price Target: $16.04
Current: $24.84
Upside: n/a
Oct 6, 2020
Maintained: Buy
Price Target: $31.60
Current: $12.41
Upside: n/a
May 22, 2019
Downgraded: Sell
Price Target: $6.57
Current: $23.59
Upside: n/a